The Stelo is available to anyone who wants to monitor their blood glucose, no prescription needed. But as an active adult without diabetes, are these extra data points worth $99 per month?

Your cozy Pokémon adventure in Pokopia begins right here in the Withered Wasteland! In this walkthrough, we’ll show you exactly how to wake up your Ditto-humanoid avatar, meet Professor Tangrowth, and ...

Rachel Pizzolato walks viewers through a Hyundai oil change, sharing a clear step-by-step tutorial for car care. American manufacturer’s hidden tag calling president "idiot" resurfaces The far-fetched ...

Investing.com -- Barclays downgraded DexCom and Insulet, two large-cap diabetes device makers, to Underweight as it expects rising competition in 2026 and 2027 to weigh on valuation multiples and ...

Learn fast gimbal setup 2025 with this DJI RS4 balancing guide and DJI RS stabilizer tutorial, showing creators how to balance their DJI RS 4 in minutes. Pixabay, ZULMAHDI Balancing the DJI RS 4 ...

The CGM provides real-time glucose readings for 15.5 days. “As a disabled veteran living with Type 2 diabetes, becoming a grandfather has given me a powerful new reason to take charge of my health,” ...

DexCom was hit with a recall and several lawsuits after some customers complained about its devices. Despite this current challenge, the medical device leader is delivering solid financial results.

Oct 31 (Reuters) - Dexcom (DXCM.O), opens new tab shares tumbled 12.8% on Friday after executives signaled that the medical device maker's 2026 growth forecast could fall short of Wall Street ...

Interim CEO Jacob Leach reported "third quarter organic revenue growth of 20% compared to the third quarter of 2024" and highlighted "solid share performance in both our U.S. and international ...

SAN DIEGO (AP) — SAN DIEGO (AP) — DexCom Inc. (DXCM) on Thursday reported third-quarter net income of $283.8 million. The San Diego-based company said it had net income of 70 cents per share. Earnings ...

July 30 (Reuters) - Dexcom (DXCM.O), opens new tab beat estimates for second-quarter results on Wednesday, driven by strong demand for its continuous glucose monitors, and named Jake Leach as its CEO.